FDA Authorizes Marketing of the First Genetic Test to Aid in the Diagnosis of Fragile X Syndrome

SILVER SPRING, Md., Feb. 21, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today authorized marketing of the first test to detect a genetic condition known as Fragile X Syndrome (FXS), the most common known cause of inherited developmental delay and intellectual disability....

from PR Newswire: https://ift.tt/38QpBDF